CLINICAL_TRIALS
trial_result
· 2021-11-30
Clinical Trial Update: Mechanisms of Refractory Hypertension (Reserpine) [Phase 2]
Summary
Phase 2 clinical trial update for reserpine in refractory hypertension has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Alabama at Birmingham | Conditions: Refractory Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2021-11-30